吳翠蓮醫生 - 泌尿外科
泌尿外科專科醫生
重點資料
- 醫務委員會註冊已驗證
- 泌尿外科專科醫生香港大學內外全科醫學士 · 香港外科醫學院院士 · 2005 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
吳翠蓮醫生是香港註冊的泌尿外科專科醫生。
學歷
保險計劃
醫院轉介
可轉介入以下私家醫院
常見問題
吳翠蓮醫生好嗎？
吳翠蓮醫生是香港註冊的泌尿外科專科醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
吳翠蓮醫生是做什麼的？
吳翠蓮醫生是泌尿外科醫生。
研究及論文
共 24 篇，顯示最近 12 篇
按論文主題篩選
主題由同一批 PubMed 論文的醫學分類整理，不代表醫生提供相關診治服務。
- Sodium-Glucose Cotransporter 2 Inhibitors for Patients With Prostate Cancer Undergoing Hormone Therapy.JAMA oncology · 2026
- Impact of Intravesical Bacillus Calmette-Guérin Therapy Following Transurethral En Bloc Resection of Bladder Tumour: Post Hoc Analysis of a Randomised, Multicentre, Phase 3 Trial.European urology oncology · 2026
- Comprehensive epidemiological analyses of urinary stone diseases in eastern China: a regional population-based study.BMC public health · 2026
- Intraoperative Ultrasound-Guided Repair of Penile Fracture: A Case Report.Case reports in urology · 2026
- Partial Nephrectomy of Renal Cell Carcinoma in Horseshoe Kidney with Assistance of Intraoperative Retrograde Pyelogram: A Case Report and Literature Review.Journal of kidney cancer and VHL · 2026
- Genetic risk and biomarker-derived cluster for urolithiasis risk prediction: a prospective cross-cohort study in the United Kingdom and Hong Kong.International journal of surgery (London, England) · 2026
- GRPR-induced FAM135A expression promote perineural invasion in prostate cancer.Molecular cancer · 2025
- Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: Protocol for a Pilot Randomized Controlled Trial.JMIR research protocols · 2025
- Profile of biological aging in first primary cancers: a pan-cancer analysis of two large-scale cohorts from the UK and Hong Kong.BMC medicine · 2025
- The Impact of Prostate-Specific Antigen Screening on Prostate Cancer Incidence and Mortality in China: 13-Year Prospective Population-Based Cohort Study.JMIR public health and surveillance · 2024
- phi and phiD predict adverse pathological features after radical prostatectomy for prostate cancer in Chinese population.Cancer medicine · 2024
- Prostate health index can stratify patients with Prostate Imaging Reporting and Data System score 3 lesions on magnetic resonance imaging to reduce prostate biopsies.Asian journal of andrology · 2024
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明